Cancer

Test Outperforms Traditional Tool in Predicting Melanoma Spread to Lymph Nodes

A prospective study shows the test more accurately identifies patients who may safely avoid biopsy compared to the Melanoma Institute Australia nomogram.

Cancer

Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types

The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.

Cancer

FDA Approves Companion Diagnostic for PTEN Loss in Prostate Cancer

The companion diagnostic identifies PTEN protein loss, helping clinicians determine which patients may benefit from Truqap in combination with abiraterone acetate.

Blood Test Shows High Sensitivity for Early-Stage Lung Cancer Detection

Jun 10, 2026 | Lung Cancer

Initial results from a real-world study of the ProVue Lung test demonstrate 83% sensitivity for Stage I cancer in high-risk patients.

Gene Test Identifies Breast Cancer Patients Who Can Safely Skip Chemotherapy

Jun 9, 2026 | Breast

Findings from the OPTIMA trial show that the Prosigna test identifies patients who can safely skip chemotherapy and use hormone therapy alone.

Urine Test Reduced Unnecessary Prostate Biopsies by 64%, Study Finds

Jun 8, 2026 | Prostate

Researchers reported that the test reduced unnecessary biopsies by up to 64% without compromising detection of aggressive prostate cancers.

Labcorp Expands DPYD Test to Identify Chemotherapy Toxicity Risk

Jun 8, 2026 | Cancer, Company News, Molecular Diagnostics

The updated test includes additional DPYD variants recommended by the Association for Molecular Pathology to help identify patients who may be at risk for severe chemotherapy side effects.

Blood Test Boosts Lung Cancer Screening Participation

Jun 8, 2026 | Lung Cancer, Molecular Diagnostics

New clinical utility data showed that offering a blood-based lung cancer test increased screening participation compared with low-dose CT screening alone.

Study Shows Blood Test Predicts Breast Cancer Recurrence Years Before Clinical Symptoms

Jun 5, 2026 | Breast, Molecular Diagnostics

Monitoring circulating tumor DNA dynamics outperformed standard markers for predicting survival and relapse in early-stage patients.

Blood Test for Colon Cancer Improves Chemotherapy Decisions, Study Finds

Jun 5, 2026 | Colorectal, Molecular Diagnostics

The study demonstrated that patients who test positive for ctDNA “actually benefit from chemotherapy.”

Study: New Mapping Method Improves Detection of Leukemia Abnormalities

Jun 4, 2026 | Cancer, Leukemia, Molecular Diagnostics

Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.